Diagenode Diagnostics logoHologic logo

News

Diagenode S.A. obtains the rights to the patents covering the detection of Norwalk-like Virus I and II
April 6, 2017

Effective as of January 1, 2017, Diagenode S.A. obtains the rights to the patents covering the detection of Norwalk-like Virus I and II:US patent No. 7,202,032, EP patent No. 1329522, US patent No. 7,351,819 and EP patent No. 1329523 under licensing agreement.


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.

© 2017 – Diagenode Diagnostics | ISO 13485 | Site Map | Privacy policy | Contact Us | Terms and Conditions |